Commission on Macroeconomics and Health

Commission on Macroeconomics and Health
Name	Commission on Macroeconomics and Health
Formed	2000
Founder	World Health Organization
Chair	Jeffrey Sachs
Region served	Global
Purpose	Assessment of health investments and macroeconomic growth

Commission on Macroeconomics and Health The Commission on Macroeconomics and Health was an expert panel convened in 2000 by the World Health Organization under the leadership of Jeffrey Sachs to examine relationships among health policy, development economics, globalization, poverty alleviation, and population health. The Commission brought together leaders from United Nations, World Bank, International Monetary Fund, Bill & Melinda Gates Foundation, and national ministries including representatives from United States Department of Health and Human Services, Ministry of Health (China), and Ministry of Health and Family Welfare (India) to produce policy guidance influencing later Millennium Development Goals and Sustainable Development Goals discussions.

Background and formation

The Commission was created amid debates involving Gro Harlem Brundtland's tenure at the World Health Organization, coordination with James Wolfensohn at the World Bank, and dialogues in Geneva and New York City about financing mechanisms modeled on precedents such as the Global Fund to Fight AIDS, Tuberculosis and Malaria and proposals circulated by the United Nations Development Programme and United Nations Millennium Project. Its membership included economists, clinicians, and policymakers drawn from institutions such as Harvard University, Columbia University, London School of Economics, Harvard School of Public Health, Johns Hopkins University, London School of Hygiene & Tropical Medicine, University of Oxford, and multilateral actors like UNICEF and GAVI.

Mandate and objectives

The Commission's mandate combined technical review and advocacy, directed to assess evidence from case studies in Brazil, China, India, South Africa, Ethiopia, and Bangladesh and to recommend resource mobilization options compatible with frameworks advanced by International Monetary Fund and World Bank country programs. Specific objectives were to quantify health investments' impacts on productivity as discussed by scholars at Brookings Institution, advise on financing mechanisms akin to proposals from the GAVI Alliance and Global Fund, and propose targets aligned with World Bank poverty reduction strategies and United Nations development agendas.

Key findings and recommendations

The Commission concluded that expanded spending on interventions for HIV/AIDS, malaria, tuberculosis, maternal health, and childhood immunization could yield measurable gains in economic growth, citing modeling exercises familiar to analysts at Harvard Kennedy School and Princeton University. It recommended increased official development assistance coordinated with World Bank lending, targeted investments in primary health care inspired by Alma-Ata Declaration principles, and the creation of global financing instruments similar to later mechanisms championed by Bill Gates and Melinda Gates. Specific recommendations referenced costing exercises undertaken by teams affiliated with Columbia University Mailman School of Public Health, University of Washington, and the London School of Hygiene & Tropical Medicine.

Impact on global health policy and financing

The report influenced agenda-setting at the G8 Summit and shaped policy dialogues at the World Health Assembly, informing the creation and scaling of initiatives such as the Global Fund to Fight AIDS, Tuberculosis and Malaria, the President's Emergency Plan for AIDS Relief, and funding approaches adopted by the Bill & Melinda Gates Foundation and World Bank. Its emphasis on economic returns from health investments resonated with finance ministers found in forums like the International Monetary Fund and contributed to shifts in United Nations development planning feeding into the formulation of the Millennium Development Goals and later the Sustainable Development Goals, as advocated by actors such as Kofi Annan and Ban Ki-moon.

Criticism and controversies

Critics from civil society organizations associated with Médecins Sans Frontières, Oxfam, People's Health Movement, and scholars at University of California, Berkeley and London School of Economics argued that the Commission over-emphasized macroeconomic framing and under-weighted rights-based approaches promoted by Amnesty International and Human Rights Watch. Debates in journals read by contributors from The Lancet and New England Journal of Medicine questioned modeling assumptions used by economists from Columbia University and Harvard University, while policy analysts at Third World Network and International Budget Partnership warned about conditionality linked to International Monetary Fund and World Bank programs.

Implementation and legacy

Elements of the Commission's agenda were implemented through expanded donor financing, the establishment of public–private partnerships modeled on GAVI and the Global Fund, and integration into country strategies supported by the World Bank and United Nations Development Programme. The legacy persists in contemporary debates involving global health security, pandemic preparedness, universal health coverage promoted at meetings of the World Health Assembly and G20 Summit, and in academic curricula at institutions such as Harvard T.H. Chan School of Public Health and London School of Hygiene & Tropical Medicine. The Commission remains cited in policy analyses by organizations including OECD, Bill & Melinda Gates Foundation, World Bank, and UNAIDS for its role in linking health investments to macroeconomic objectives.

Category:Global health Category:World Health Organization convenings